Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Biophys J ; 106(11): 2434-42, 2014 Jun 03.
Artigo em Inglês | MEDLINE | ID: mdl-24896122

RESUMO

The bending of cilia and flagella is driven by forces generated by dynein motor proteins. These forces slide adjacent microtubule doublets within the axoneme, the motile cytoskeletal structure. To create regular, oscillatory beating patterns, the activities of the axonemal dyneins must be coordinated both spatially and temporally. It is thought that coordination is mediated by stresses or strains, which build up within the moving axoneme, and somehow regulate dynein activity. During experimentation with axonemes subjected to mild proteolysis, we observed pairs of doublets associating with each other and forming bends with almost constant curvature. By modeling the statics of a pair of filaments, we show that the activity of the motors concentrates at the distal tips of the doublets. Furthermore, we show that this distribution of motor activity accords with models in which curvature, or curvature-induced normal forces, regulates the activity of the motors. These observations, together with our theoretical analysis, provide evidence that dynein activity can be regulated by curvature or normal forces, which may, therefore, play a role in coordinating the beating of cilia and flagella.


Assuntos
Dineínas do Axonema/química , Axonema/metabolismo , Chlamydomonas reinhardtii/metabolismo , Modelos Biológicos , Trifosfato de Adenosina/metabolismo , Dineínas do Axonema/metabolismo , Axonema/ultraestrutura , Resistência ao Cisalhamento , Resistência à Tração
2.
Urologe A ; 52(1): 15-6, 18-20, 2013 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-23340723

RESUMO

Bladder dysfunction in children is a very common and heterogeneous problem. There can be disturbances either in bladder storage or during voiding phases. First of all it is important to distinguish between non-neurogenic and neuropathic bladder dysfuction. In this article the most common causes, the basic diagnostic evaluation and therapeutic interventions are summarized.


Assuntos
Doenças da Bexiga Urinária/diagnóstico , Doenças da Bexiga Urinária/terapia , Transtornos Urinários/diagnóstico , Transtornos Urinários/terapia , Criança , Humanos
3.
Eur J Cancer ; 48(1): 1-11, 2012 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21741830

RESUMO

AIM OF THE STUDY: Clinical practice guidelines (CPG) are an appropriate method to optimise routine clinical care. Numerous CPGs for the diagnosis and treatment of breast cancer have been developed by national health institutions or medical societies. While a comparison of methodological criteria has been undertaken before, it is unknown whether these CPGs differ in their actual treatment recommendations. METHODS: We included national breast cancer CPGs from the USA, Canada, Australia, the UK, and Germany that satisfy internationally recognised methodological criteria and are in widespread use in daily clinical care. Treatment recommendations for adjuvant invasive breast cancer including surgery, radiation, endocrine therapy, chemotherapy and anti-HER2-therapy were compared. RESULTS: Recommendations for endocrine therapy show discordances regarding optimal usage of ovarian function suppression for premenopausal patients and aromatase inhibitors for postmenopausal patients. However, most other treatment recommendations exhibit a large degree of congruency. This reflects the fact that they rest on the same evidence base, and that many national guidelines are adopted from other guidelines so that well accepted guidelines are cited within other guidelines. CONCLUDING STATEMENT: Considering that the development of guidelines is a very expensive and resource-intensive task the question arises whether the development of national guidelines in numerous countries is worth the effort since the recommendations differ only marginally.


Assuntos
Neoplasias da Mama/terapia , Carcinoma/terapia , Oncologia/legislação & jurisprudência , Oncologia/métodos , Guias de Prática Clínica como Assunto , Antineoplásicos Hormonais/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Neoplasias da Mama/patologia , Carcinoma/patologia , Governo Federal , Feminino , Humanos , Internacionalidade , Mastectomia/métodos , Mastectomia/estatística & dados numéricos , Gradação de Tumores , Inibidores de Proteínas Quinases/uso terapêutico , Radioterapia/estatística & dados numéricos , Receptor ErbB-2/antagonistas & inibidores , Estados Unidos
4.
Urologe A ; 50(6): 725-34, 2011 Jun.
Artigo em Alemão | MEDLINE | ID: mdl-21656096

RESUMO

The current management of vesicoureteral reflux (VUR) remains controversial. Recent well thought-out randomized studies on VUR in children have led to a debate on diagnostic and therapeutic algorithms. Individual parameters, such as age, gender, clinical course, renal function and scars, dysfunctional elimination syndrome and last but not least the compliance of the parents have gained in importance. Regarding recent data this article gives a summary of diagnostic steps and therapeutic management of VUR.


Assuntos
Refluxo Vesicoureteral/diagnóstico , Refluxo Vesicoureteral/terapia , Algoritmos , Antibacterianos/administração & dosagem , Criança , Pré-Escolar , Estudos Transversais , Cistoscopia , Dextranos/administração & dosagem , Diagnóstico Diferencial , Feminino , Predisposição Genética para Doença/genética , Humanos , Ácido Hialurônico/administração & dosagem , Lactente , Recém-Nascido , Assistência de Longa Duração , Masculino , Programas de Rastreamento , Prognóstico , Implantação de Prótese , Pielonefrite/diagnóstico , Pielonefrite/epidemiologia , Pielonefrite/etiologia , Pielonefrite/terapia , Ultrassonografia , Ureter/cirurgia , Ureteroscopia , Bexiga Urinária/cirurgia , Urografia , Procedimentos Cirúrgicos Urológicos , Refluxo Vesicoureteral/epidemiologia , Refluxo Vesicoureteral/genética
5.
Urologe A ; 46(1): 66, 68, 2007 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-16960728

RESUMO

We present a rare case of cystitis emphysematosa in an 85-year-old female patient in whom the typical risk factors were present: diabetes of long standing, neurogenic bladder and urinary infection with E.coli. Thanks to early diagnosis by cystoscopy and abdominal CT, after antibiotic treatment, appropriate insulin therapy and continuous bladder drainage the course was uneventful. The patient was fit to leave hospital after 14 days.


Assuntos
Cistite/etiologia , Complicações do Diabetes , Enfisema/etiologia , Bexiga Urinaria Neurogênica/complicações , Infecções Urinárias/complicações , Idoso de 80 Anos ou mais , Cistite/diagnóstico , Cistite/terapia , Complicações do Diabetes/diagnóstico , Complicações do Diabetes/terapia , Enfisema/diagnóstico , Enfisema/terapia , Feminino , Humanos , Bexiga Urinaria Neurogênica/diagnóstico , Bexiga Urinaria Neurogênica/terapia , Infecções Urinárias/diagnóstico , Infecções Urinárias/terapia
6.
Scand J Rheumatol Suppl ; 119: 9-11, 2004.
Artigo em Inglês | MEDLINE | ID: mdl-15515405

RESUMO

There is evidence from both human and animal research that 5-hydroxytryptamine3 (5-HT3) receptor antagonists, particularly tropisetron, exert analgesic and antiinflammatory effects. However, the underlying mechanisms of these effects including the expression of 5-HT3 receptors in cells of the immune system have not yet been investigated in detail. Therefore, we investigated the expression of the 5-HT3A receptor in primary human monocytes, chondrocytes, T-cells, dendritic cells, and synovial tissue. We found that 5-HT3A receptors are expressed in monocytes, chondrocytes, T-cells, and synovial tissue but not in dendritic cells. Our data show that 5-HT3A receptors are widely expressed in cells of the immune system and that they might play an important role in inflammatory events and in the observed antiphlogistic effects of 5-HT3 receptor antagonists.


Assuntos
Receptores 5-HT3 de Serotonina/biossíntese , Células Dendríticas/imunologia , Humanos , Sistema Imunitário/citologia , Sistema Imunitário/fisiologia , Monócitos/imunologia , Linfócitos T/imunologia
7.
Urologe A ; 32(1): 59-63, 1993 Jan.
Artigo em Alemão | MEDLINE | ID: mdl-8447047

RESUMO

A female patient is presented who had a large carcinosarcoma of the urinary bladder that became clinically manifest only 2 months before treatment. The initial treatment by transurethral resection was followed by radical cystectomy; 7 months postoperatively the patient died of local tumour recurrence with widespread metastases. Carcinosarcoma of the urinary bladder is a rare tumour with a poor prognosis. The majority of such tumours are not diagnosed until tumour growth is already far advanced. Owing to the small number of cases there is no clinically proven form of management. In contrast with superficial transitional cell carcinoma of the bladder, superficial carcinosarcoma of the bladder has always invaded the lamina propria, since in addition to the carcinomatous degeneration of the mucosa, sarcomatous degeneration of the underlying submucosal stroma is also present. Any local surgical treatment, such as TUR or partial cystectomy, involves the risk of incomplete tumor removal, because the sarcomatous elements typically invade the submucosa while the overlying mucosa remains intact. Therefore, radical cystectomy appears to be the treatment of choice for both superficial and invasive carcinosarcoma of the urinary bladder.


Assuntos
Carcinossarcoma/cirurgia , Neoplasias da Bexiga Urinária/cirurgia , Carcinossarcoma/patologia , Cistectomia , Feminino , Humanos , Pessoa de Meia-Idade , Recidiva Local de Neoplasia/patologia , Recidiva Local de Neoplasia/cirurgia , Bexiga Urinária/patologia , Neoplasias da Bexiga Urinária/patologia , Coletores de Urina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA